Abstract

Background: After recovery from COVID-19, patients frequently face so-called “Post-COVID-19 Syndrome” defined by clusters of persistent symptoms lasting for >12 weeks which may arise from any system in the body. The long-term health consequences of COVID-19 in maintenance hemodialyzed (HD) patients remain to be investigated. Methods: In this longitudinal cohort study we described the health consequences in HD patients requiring hospitalization due to COVID-19. They were interviewed three and six months (M3 and M6) after discharge with a series of standardized questionnaires. Results: Of 144 HD patients discharged from the 7th Naval Hospital in Gdansk, 79 participants were enrolled, 39 m (49.4%) and 40 f (50.6%) with a median age of 70.0 (64.0–76.5) and an HD vintage of 40 months (17.5–88). After discharge, 93.7% and 81% reported at least one persistent symptom at M3 and M6, respectively. The most common symptoms were fatigue or muscle weakness (60.76% and 47.04%) and palpitations (40.51% and 30.14%). Dyspnea with an mMRC scale grade of at least 1 was reported by 21.5% before infection, and by 43.03% and 34.25% at M3 and M6, respectively. A decrease in the quality of life was reported in all domains of the EQ-5D-5L questionnaire but mainly in the pain/discomfort and anxiety dimensions. Mean EQ-VAS scores were 69.05, 61.58 and 64.38, respectively. Conclusion: Our study showed that HD patients may still experience persistent symptoms six months after recovery from COVID-19, which can further reduce their already poor health-related quality of life. This study highlights the need for long-term follow-up on these patients for diagnostic and rehabilitation programs.

Highlights

  • Recovery from COVID-19 can usually take several weeks in patients with mild to moderate symptoms

  • Three (M3) and six months (M6) after discharge from the hospital, all patients who consented to participate in the study were telephone-interviewed by trained medical students with questionnaires investigating specific persistent or emerging symptoms potentially associated with COVID-19 and the quality of their lives

  • A total of 206 adult HD patients were hospitalized with confirmed COVID-19 between

Read more

Summary

Introduction

Recovery from COVID-19 can usually take several weeks in patients with mild to moderate symptoms. Some patients fully recover, several observational studies have shown that a large proportion of subjects suffer from debilitating symptoms weeks and even months after COVID-19 diagnosis; among these symptoms the most common are fatigue, shortness of breath, chest tightness, headache and muscle pain [1,2] This so-called “long COVID-19 syndrome” is defined as persistent symptoms and/or delayed or long-term complications of SARS-CoV-2 infection beyond four weeks from the onset of symptoms, and includes subacute or ongoing symptomatic COVID-19 (4–12 weeks beyond acute COVID-19); and post-COVID-19 syndrome, which includes symptoms and abnormalities persisting or present beyond 12 weeks from the onset of acute COVID-19, and not attributable to alternative diagnoses [3]. Dyspnea with an mMRC scale grade of at least 1 was reported by 21.5% before infection, and by 43.03% and 34.25% at M3 and M6, respectively

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call